Concepedia

David Baanstra

DB

Statistics

Publications

8

Citations

5.6K

H-Index

8

Active since

2009

Affiliations

Boehringer Ingelheim (Netherlands)(Current)

Boehringer Ingelheim (Norway)

Brigham and Women's Hospital

Boehringer Ingelheim (Germany)

Sahlgrenska University Hospital

David Baanstra is an author at Boehringer Ingelheim (Netherlands) specializing in clinical pharmacology, pharmacotherapy, and pharmacology.

Publications per year

2009–2019

8

Publications

8

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

Sam Schulman, Clive Kearon, Ajay K. Kakkar et al. · New England Journal of Medicine · 2009 · 2.6K citations · Full text

, , +12

Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk

Julio Rosenstock, Vlado Perkovic, Odd Erik Johansen et al. · JAMA · 2018 · 1.1K citations · Full text

, , +11

Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism

Sam Schulman, Clive Kearon, Ajay K. Kakkar et al. · New England Journal of Medicine · 2013 · 990 citations · Full text

, , +12

Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes

Julio Rosenstock, Steven E. Kahn, Odd Erik Johansen et al. · JAMA · 2019 · 606 citations · Full text

, , +17

Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA

Darren K. McGuire, John H. Alexander, Odd Erik Johansen et al. · Circulation · 2019 · 163 citations · Full text

, , +10

1–5 of 8